In a first, FDA approves drug meant to mitigate symptoms of opioid withdrawal

In a first, FDA approves drug meant to mitigate symptoms of opioid withdrawal

Source: 
Stat
snippet: 

The Food and Drug Administration on Wednesday approved for the first time a drug meant to mitigate the symptoms of opioid withdrawal — rather than an underlying dependency — giving American physicians a new tool to help patients begin treatment.

The drug, lofexidine, will be manufactured by Kentucky-based US WorldMeds and marketed as Lucemyra.